VRCA
Verrica Pharmaceuticals Inc
4.20$
+1.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -147.4% | – | – | – | |
| – | +3.3% | +56.7% | -1.8% | +2.4% | -26.0% | -17.8% | -43.3% | +55.9% | -5.4% | +11.5% | +6.7% | – | |
| – | -78.5% | -0.1% | +7.5% | -5.4% | -64.1% | +35.7% | -13.5% | -19.1% | -4.5% | +30.8% | +35.2% | – | |
| – | – | -151.6% | – | – | -137.1% | – | – | – | -74.7% | -200.6% | – | – | |
| – | +249.2% | -100.0% | – | +45.5% | -100.0% | – | – | – | – | – | – | – | |
| – | +249.2% | – | – | +45.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +597.7% | +168.0% | +2.4% | -4.1% | +803.8% | -99.7% | +13.5% | – | |
| – | -100.1% | +2,348.1% | -3.2% | -38.0% | – | -110.3% | +2.4% | -4.1% | – | -100.9% | +5.0% | – | |
| – | -150.6% | – | – | – | – | -171.6% | – | – | +58.7% | -205.5% | – | – | |
| – | – | – | – | – | – | – | – | – | -147.4% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.